Axworthy D., Marteau T.M., Brock D.J.H. and Bobrow M.
1996: Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. The Lancet
Bloss C.S., Schork N.J. and Topol E.J.
2011: Effect of direct-to-consumer genomewide profiling to assess disease risk. New England Journal of Medicine
Drenos F., Whittaker J.C. and Humphries S.E.
2007: The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. Annals of Human Genetics
Goldsmith L., Jackson L., O’Connor A. and Skirton H.
2012: Direct-to-consumer genomic testing: systematic review of the literature on user perspectives. European Journal of Human Genetics
Grant R.W., O’Brien K.E., Waxler J.L., Vassy J.L., Delahanty L.M., Bissett L.G. and Green R.C.
2013: Personalized genetic risk counselling to motivate diabetes prevention. Diabetes Care
Henrikson N.B., Bowen D. and Burke W.
2009: Does genomic risk information motivate people to change their behavior?
Hippisley-Cox J., Coupland C., Robson J. and Brindle P.
2010: Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. British Medical Journal
Holmes M.V., Harrison S., Talmud P.J., Hingorani A. and Humphries S.E.
2011: Utility of genetic determinants of lipids and cardiovascular events in assessing risk. Nature Reviews Cardiology
Hughes M.F., Saarela O., Strizke J., Kee F., Silander K., Klopp N., Kontto J., Karvanen J., Willenborg C., Salomaa V., Viramo J. and Amouyel P.
2012: Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts. PLoS One
Humphries S.E., Drenos F., Ken-Dror G. and Talmud P.J.
2010: CHD risk prediction in the GWAS/OMICS Era: current status and what the future holds. Circulation
Liang B.A. and Mackey T.
2011: Direct-to-consumer advertising with interactive internet media: global regulation and public health issues. The Journal of the American Medical Association
Lippi G., Favaloro E.J. and Plebani M.
2011: Direct-to-consumer testing: more risks than opportunities. International Journal of Clinical Practice
Marteau T. and Bekker H.T.
1992: The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). British Journal of Clinical Psychology
1989: Psychological costs of screening. British Medical Journal
Marteau T.M., French D.P., Griffin S.J., Prevost A.T., Sutton S., Watkinson C., Attwood S. and Hollands G.J.
2010: Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database of Systematic Reviews
Meisel S.F., Walker C. and Wardle J.
2012: Psychological responses to genetic testing for weight gain: a vignette study. Obesity
Middlemass J.B., Yazdani M.F., Kai J., Standen P.J. and Qureshi N.
2014: Introducing genetic testing for cardiovascular disease in primary care: a qualitative study. British Journal of General Practice
National Cholesterol Education Program Expert Panel (NCEP). 2002: Third report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation
National Institute for Health and Clinical Excellence. 2014. NICE clinical guideline 181 lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: NICE.
NHS Health Check Programme. 2009. Putting prevention first – vascular checks: risk assessment and management. London: Department of Health.
Prochaska J.O., Velicer W.F., Redding C., Rossi J.S., Goldstein M., DePue J., Greene G.W., Rossi S.R., Sun X., Fava J.L., Laforge R., Rakowski W. and Plummer B.A.
2005: Stage-based expert systems to guide a population of primary care patients to quit smoking, eat healthier, prevent skin cancer, and receive regular mammograms. Preventive Medicine
Qureshi N., Armstrong S., Dhiman P., Saukko P., Middlemass J., Evans P.H. and Kai J.
2012: Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Annals of Internal Medicine
Roe L., Strong C., Whiteside C., Neil A. and Mant D.
1994: Dietary intervention in primary care: validity of the DINE method for diet assessment. Family Practice
Roger V.L., Go A.S., Lloyd-Jones D.M.l., Benjamin E.J., Berry J.D., Borden W.B.
On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2012: Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation
Rose P., Humm E., Hey K., Jones L. and Huson S.M.
1999: Family history taking and genetic counselling in primary care. Family Practice
Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R. and Jacobs G.A.
1983: Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
Senior V., Marteau T. and Peters T.
1999: Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Social Science & Medicine
Swerdlow D., Holmes M.V., Harrison S. and Humphries S.E.
2012: The genetics of coronary heart disease. British Medical Bulletin
Talmud P.J., Cooper J.A., Palmen J., Lovering R., Drenos F., Hingorani A.D. and Humphries S.E.
2008: Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clinical Chemistry
Task Force Report.
1998: Prevention of coronary heart disease in clinical practice. recommendations of the second joint task force of European and other societies on coronary prevention. European Heart Journal
The Wellcome Trust Case Control Consortium. 2007: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature
U.S. Department of Health and Human Services (DHSS).
2008. Physical Activity Guidelines for Americans. Washington, DC: DHSS.
Wood D., Durrington D., McInnes G., Poulter N., Rees A. and Wray R.
1998: Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart
80 (Suppl 2), s1–s29.
Wood D., Wray R., Poulter N., Williams B., Kirby M., Patel V., Durrington P., Reckless J., Davis M., Sivers F. and Potter J.
2005: JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart
91 (Suppl 5), v1–v52.